الصفحة الرئيسية>>Signaling Pathways>> Neuroscience>> Dopamine Receptor>>UCM-1306

UCM-1306 (Synonyms: 2-(Fluoromethoxy)-4'-(S-methylsulfonimidoyl)-1,1'-biphenyl)

رقم الكتالوجGC70086

UCM-1306 هو عامل تنظيمي لتحولات مستقبلات الدوبامين D1 الفعال عن طريق الفم. يزيد UCM-1306 من أقصى تأثير الدوبامين (DA) الموروث في مستقبلات D1 للإنسان والفئران. بالإضافة إلى تحسين أعراض الحركة ، يمكن لـ UCM-1306 حل المشاكل المهمة المتعلقة بارتجاج التذكر في Parkinson's disease (PD).

Products are for research use only. Not for human use. We do not sell to patients.

UCM-1306 التركيب الكيميائي

Cas No.: 2258608-78-3

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
103٫00
متوفر
1mg
33٫00
متوفر
5mg
83٫00
متوفر
10mg
129٫00
متوفر
25mg
221٫00
متوفر
50mg
322٫00
متوفر
100mg
460٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com


مراجعات العميل

بناء على آراء العملاء.

Sample solution is provided at 25 µL, 10mM.

Chemical Properties of UCM-1306

Cas No. 2258608-78-3 SDF
المرادفات 2-(Fluoromethoxy)-4'-(S-methylsulfonimidoyl)-1,1'-biphenyl
Formula C14H14FNO2S M.Wt 279.33
الذوبان DMSO : 50 mg/mL (179.00 mM; Need ultrasonic) Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of UCM-1306

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 3.58 mL 17.9 mL 35.7999 mL
5 mM 716 μL 3.58 mL 7.16 mL
10 mM 358 μL 1.79 mL 3.58 mL
  • حاسبة المولارية

  • حاسبة التخفيف

  • Molecular Weight Calculator

كتلة
=
تركيز
x
مقدار
x
ميغاواط *
 
 
 
** عند إعداد حلول المخزون، دائمًا استخدم الوزن الجزيئي الخاص بالدفعة للمنتج على ملصق القارورة MSDS / CoA (متوفر عبر الإنترنت).

احسب

In vivo Formulation Calculator (Clear solution) of UCM-1306

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

مراجعات

Review for UCM-1306

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for UCM-1306

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.